Executive Team
-
John Manusu
Executive Chairman
Mr Manusu has over 20 years experience running biotechnology companies. Throughout this period he has been involved with start ups, turnarounds and mature organisations in the biotechnology space. Mr Manusu has undertaken a number of significant acquisitions and divestures, as well as raising over $100 million in public funding and $10 million of peer reviewed government R&D grants. Mr Manusu has a degree in Commerce and is a Fellow of the Financial Services Institute of Australasia. Mr Manusu has worked in the Australia and U.S. Biotechnology markets and is best described as a biotechnology entrepreneur.
-
Dr Hari Nair
Managing Director and CEO
Dr Nair has a PhD in Medicine and Clinical Science from the Australian National University with his specialty in cardiovascular medicine and haematology. Dr Nair has received a number of awards from international organisations including being specially recognised for his role in coagulation research by the ACT government. He has run biotechnology companies in Australia and the US. Dr Nair has been heavily involved in mergers and acquisitions especially in the US and Europe and has US financial experience. Dr Nair has served on the boards of a number of international biotechnology companies and US state Commercialisation Boards. -
Prakash Patel
Chief Operating Officer and Company Secretary
Mr Patel has a degree in Commerce and is a CPA, he has several years of post qualification experience holding senior roles in listed multinational companies working both in Sydney and the United Kingdom. Mr Patel has overall responsibility for all aspects of the group operations and has a lead role in commercial decision-making across the business. Mr Patel is also responsible for all dealings with the Australian Stock Exchange, Investors and Shareholders. -
Matthew Loggie
General Manager (Australia)
Mr Loggie has a background in electronics and over 30 years experience in the Australian manufacturing sector. With 20 years in the export market, and 10 of those specialising in the mass spectrometry field, Mr Loggie has extensive knowledge of the intricacies of the industry. Mr Loggie is responsible for the Australian Operation and ensuring the objectives for sustainable and profitable growth are achieved. -
Dr John Andrews
Vice-President Science and Technology
Dr Andrews has in excess of 20 years skilled practice in chemistry/biochemistry R&D, particularly separations science and protein chemistry, across the biomedical, agricultural and biotechnology industries. He has a BA (Honours-I-Chemistry) from Macquarie University and a PhD from the University of Sydney. Working under a range of regulatory environments (GMP/GLP/ISO), he has significant experience in areas of production, product/process development and analytical/process validation. He has managed research, process development and production teams, of varying sizes, at institutions such as Bond University, CSIRO, Biotech Australia and Gropep. -
Dr James Atwood III
General Manager (US)
Dr Atwood co-founded BioInquire in 2006 (developer of ProteoIQ software) which NuSep acquired in 2010. As General Manager (US) he is responsible for advancing the company's vision for new innovations and growing its customer base. He brings over ten years of research experience in proteomics and glycomics with numerous proteomics publications and patents. Dr Atwood holds a PhD in Chemistry from the University of Georgia. -
Dr Kailing Wang
Chief Scientific Officer
Dr Wang obtained her PhD in biochemistry at the University of Sydney in 1997. She has over 15 years of research experience in the field of protein biochemistry, molecular biology, cell biology and virology. Prior to joining NuSep Ltd, she was a Business Development Manager at Sydnovate, the commercial arm of the University of Sydney where she was responsible for developing commercialisation opportunities across research translation continuum. Her commercial experience includes developing and implementing marketing strategies for high value technology-based products, business operation management, technology licensing and IP management.
